Tyrosinase
TYR | |||
---|---|---|---|
Identifiers | |||
Gene ontology | |||
Molecular function | |||
Cellular component | |||
Biological process | |||
Sources:Amigo / QuickGO |
Ensembl | |||||||||
---|---|---|---|---|---|---|---|---|---|
UniProt | |||||||||
RefSeq (mRNA) | |||||||||
RefSeq (protein) | |||||||||
Location (UCSC) | Chr 11: 89.18 – 89.3 Mb | Chr 7: 87.07 – 87.14 Mb | |||||||
PubMed search | [3] | [4] |
View/Edit Human | View/Edit Mouse |
Tyrosinase is an oxidase that is the rate-limiting enzyme for controlling the production of melanin. The enzyme is mainly involved in two distinct reactions of melanin synthesis otherwise known as the Raper Mason pathway. Firstly, the hydroxylation of a monophenol and secondly, the conversion of an o-diphenol to the corresponding o-quinone. o-Quinone undergoes several reactions to eventually form melanin.[5] Tyrosinase is a copper-containing enzyme present in plant and animal tissues that catalyzes the production of melanin and other pigments from tyrosine by oxidation. It is found inside melanosomes which are synthesized in the skin melanocytes. In humans, the tyrosinase enzyme is encoded by the TYR gene.[6]
Catalyzed reaction
Tyrosinase carries out the oxidation of phenols such as tyrosine and dopamine using dioxygen (O2). In the presence of catechol, benzoquinone is formed (see reaction below). Hydrogens removed from catechol combine with oxygen to form water.
The substrate specificity becomes dramatically restricted in mammalian tyrosinase which uses only L-form of tyrosine or DOPA as substrates, and has restricted requirement for L-DOPA as cofactor.[7]
Active site
monophenol monooxygenase | |||||||||
---|---|---|---|---|---|---|---|---|---|
ExPASy NiceZyme view | | ||||||||
KEGG | KEGG entry | ||||||||
MetaCyc | metabolic pathway | ||||||||
PRIAM | profile | ||||||||
PDB structures | RCSB PDB PDBe PDBsum | ||||||||
Gene Ontology | AmiGO / QuickGO | ||||||||
|
Tyrosinase | |||||||||
---|---|---|---|---|---|---|---|---|---|
|
Common central domain of tyrosinase | |||||||||
---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||
Symbol | Tyrosinase | ||||||||
SCOP2 | 1hc2 / SCOPe / SUPFAM | ||||||||
|
The two copper atoms within the active site of tyrosinase enzymes interact with
Structure
Tyrosinases have been isolated and studied from a wide variety of plant, animal, and fungal species. Tyrosinases from different species are diverse in terms of their structural properties, tissue distribution, and cellular location.[9]
No common tyrosinase protein structure occurring across all species has been found.
Plant
Mammalian
Mammalian tyrosinase is a single membrane-spanning
As opposed to fungal tyrosinase, human tyrosinase is a membrane-bound glycoprotein and has 13% carbohydrate content.[14]
The derived TYR allele (rs2733832) is associated with lighter skin pigmentation in human populations. It is most common in Europe, but is also found at lower, moderate frequencies in Central Asia, the Middle East, North Africa, and among the San and Mbuti Pygmies.[15]
Bacterial
In peatlands, bacterial tyrosinases are proposed to act as key regulators of carbon storage by removing phenolic compounds, which inhibit the degradation of organic carbon.[16]
Gene regulation
The gene for tyrosinase is regulated by the microphthalmia-associated transcription factor (MITF).[17][18]
Clinical significance
A mutation in the tyrosinase gene resulting in impaired tyrosinase production leads to type I oculocutaneous albinism, a hereditary disorder that affects one in every 20,000 people.[20]
Tyrosinase activity is very important. If uncontrolled during the
Several polyphenols, including flavonoids or stilbenoid, substrate analogues, free radical scavengers, and copper chelators, have been known to inhibit tyrosinase.[22] Henceforth, the medical and cosmetic industries are focusing research on tyrosinase inhibitors to treat skin disorders.[5]
Inhibitors
Known Tyrosinase inhibitors are the following:[23]
Genetics
While albinism is common, there have only been a few studies about the genetic mutations in the tyrosinase genes of animals. One of them was on Bubalus bubalis (water buffalo). The tyrosinase mRNA sequence of the wild-type B. bubalis is 1,958 base pairs (bp) with an open reading frame (ORF) of 1,593 bp long, which translates to 530 amino acids. Meanwhile, the tyrosinase gene of the albino B. bubalis (GenBank JN_887463) is truncated at position 477, caused by a point mutation in nucleotide 1431 which converts a Tryptophan (TGG) into a stop codon (TGA), resulting in a shorter and inactive tyrosinase gene.[24] Other albinos have point mutations that appear to inactivate Tyrosinase without truncation (see table and figure for examples).
Species | Common name | Amino Acid mutation | GenBank | Uniprot ID |
---|---|---|---|---|
Bubalus bubalis | Water Buffalo | W477 -> Stop codon | JN_887462 | J7FBF2 |
Pelophylax nigromaculatus | Pond Frog | Deletion of a K228 | Q04604 | |
Glandirana rugosa | Wrinkled Frog | G376 -> D376 | A0A1I9FZH0 | |
Fejervarya kawamurai | Rice Frog | G57 -> R57 | A0A1E1G7U0 |
Knowing that there are a few studies about the genomic data of the tyrosinase gene, there are only a handful of studies on the mutations in albino amphibians. Miura et al. (2018) investigates the amino acid mutations in the tyrosinase gene in three albino frogs: Pelophylax nigromaculatus (pond frog), Glandirana rugosa (wrinkled frog) and Fejervarya kawamurai (rice frog). In total, five different populations were studied of which three were P. nigromaculatus and one each of G. rugosa and F. kawamurai. In two of the three P. nigromaculatus populations, there was a frameshift mutation because of the insertion of a thymine within exons 1 and 3, and the third population lacked three nucleotides that encoded a Lysine in exon 1. The population of G. rugosa had a missense mutation where there was an amino acid substitution from a Glycine to Aspartic acid, and the mutation of F. kawamurai was also an amino acid substitution from Glycine to Arginine. The mutation for G. rugosa and F. kawamurai occurs in exons 1 and 3. The mutations of the third population of P. nigromaculatus, and the mutations of G. rugosa and F. kawamurai occurred in areas that are highly conserved among vertebrates which could result in a dysfunctional tyrosinase gene.[25]
Evolution
Tyrosinase is a highly conserved protein in animals and apparently arose already in
Applications
In the food industry
In the food industry, tyrosinase inhibition is desired as tyrosinase catalyzes the oxidation of
In the cosmetic industry
Lighter skin complexion has been associated with youth and beauty across various Asian cultures. Recent research by cosmetic companies has been focused on the development of novel whitening agents that selectively suppress tyrosinase activity to reduce hyperpigmentation while avoiding cytotoxicity of healthy melanocytes.[35] Traditional pharmacological agents such as corticosteroids, hydroquinone, and amino numeric chloride lighten skin through the inhibition of melanocyte maturation.[36] However, these agents are associated with adverse effects. Cosmetic companies have been focused on developing novel whitening agents that selectively suppress the activity of tyrosinase to reduce hyperpigmentation while avoiding melanocyte cytotoxicity as tyrosinase is the rate-limiting step of the melanogenesis pathway.
In insects
Tyrosinase has a wide range of functions in insects, including wound healing, sclerotization, melanin synthesis and parasite encapsulation. As a result, it is an important enzyme as it is the defensive mechanism of insects. Some insecticides are aimed to inhibit tyrosinase.[14]
In mussel-glue inspired polymers
Tyrosinase activated
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000077498 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000004651 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ PMID 21144881.
- PMID 3146546.
- PMID 6766744.
- PMID 16436386.
- PMID 16973188.
- PMID 12466021.
- PMID 16973188.
- PMID 2823263.
- PMID 16162817.
- ^ S2CID 8280251.
- ^ "Allele Frequency For Polymorphic Site: rs2733832". ALFRED. Archived from the original on 20 August 2016. Retrieved 23 June 2016.
- PMID 34156250.
- PMID 11076759.
- PMID 19067971.
- ^ M. S. Eller, K. Ostrom, and B. A. Gilchrest, “DNA damage enhances melanogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 3, pp. 1087–1092, 1996
- PMID 546241.
- PMID 17218941.
- PMID 19582213.
- PMID 28097901.
- PMID 22817390.
- ^ PMID 28674275.
- PMID 28756020.
- PMID 12039032.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 22536431.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 23634722.
- PMID 16493586.
- S2CID 12589166.
- PMID 12530473.
- PMID 19043197.
- PMID 21125547.
- ^ Qian, W., Liu, W., Zhu, D., Cao, Y., Tang, A., Gong, G., Su, H."Natural skin‑whitening compounds for the treatment of melanogenesis (Review)". Experimental and Therapeutic Medicine 20.1 (2020): 173-185.
- ^ Lajis AFB and Ariff AB: Discovery of new depigmenting compounds and their efficacy to treat hyperpigmentation: Evidence from in vitro study. J Cosmet Dermatol. 18:703–727. 2019.
- PMID 30246912.
- PMID 32596967.
External links
- GeneReviews/NCBI/NIH/UW entry on Oculocutaneous Albinism Type 1
- Tyrosinase at the U.S. National Library of Medicine Medical Subject Headings (MeSH)